All Stories

  1. Influence of temperament and emotional dysregulation on depressive symptoms in adults with attention-deficit/hyperactivity disorder: A structural equation modelling analysis
  2. Complete blood count-based inflammation indexes and symptom severity in people with schizophrenia spectrum disorders: An analysis based on structural equation modelling
  3. Mood Disorder Questionnaire Positivity in Systemic Lupus Erythematosus and Other Chronic Diseases including Screen Bipolar Disorders or Rhythm and Energy Dysregulation Syndromes (DYMERS)
  4. Anti-obesity Drugs for the Treatment of Binge Eating Disorder: Opportunities and Challenges
  5. Influence of prior contact with community mental health services on first inpatient psychiatric admission for ethnic minorities: Findings from the NOMIAC study
  6. Correction: Type of cycle, temperament and childhood trauma are associated with lithium response in patients with bipolar disorders
  7. Substance use disorders in adults with attention-deficit/hyperactivity disorder: The role of affective temperament
  8. Combining predominant polarity and affective spectrum concepts in bipolar disorder: towards a novel theoretical and clinical perspective
  9. Evidence from preclinical and clinical metabolomics studies on the antidepressant effects of ketamine and esketamine
  10. Prevalence and correlates of manic/hypomanic and depressive predominant polarity in bipolar disorder: systematic review and meta-analysis
  11. Type of cycle, temperament and childhood trauma are associated with lithium response in patients with bipolar disorders
  12. Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial
  13. Understanding University Students' Perspectives towards Digital Tools for Mental Health Support: A Cross-country Study
  14. Longitudinal outcomes of a work inclusion program in mental health departments in the city of Milan
  15. The Kynurenine Pathway in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Blood Concentrations of Tryptophan and Its Catabolites
  16. The interplay between mentalization, personality traits and burnout in psychiatry training: Results from a large multicenter controlled study
  17. Exploring depression in people with schizophrenia spectrum disorders: A cross-sectional analysis of the clinical relationship with Positive and Negative Syndrome Scale dimensions
  18. Blood concentrations of anterior pituitary hormones in drug-naïve people with first-episode psychosis: A systematic review and meta-analysis
  19. Acute stress symptoms in general population during the first wave of COVID lockdown in Italy: Results from the COMET trial
  20. Influence of intrinsic and extrinsic religiosity on youth cannabis use: A structural equation modelling analysis on national survey on drug use and health (NSDUH) 2015–2019
  21. The impact of MDQ positivity on quality of life impairment: Does it support the hypothesis of “Dysregulation of Mood, Energy, and Social Rhythms Syndrome” (DYMERS)?
  22. The effect of social media and infodemic on mental health during the COVID-19 pandemic: results from the COMET multicentric trial
  23. Anxious distress in people with major depressive episodes: a cross-sectional analysis of clinical correlates
  24. The role of BDNF in major depressive disorder, related clinical features, and antidepressant treatment: Insight from meta-analyses
  25. Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study
  26. Characterizing the clinical profile of mania without major depressive episodes: a systematic review and meta-analysis of factors associated with unipolar mania
  27. Anterior pituitary hormones in first-episode psychosis: a systematic review and meta-analysis
  28. Clinical factors associated with unipolar mania: A systematic review and meta-analysis
  29. Mental health and COVID-19 in university students: a qualitative study comparing Italy and the UK
  30. Mental Health and COVID-19 in University Students: Findings from a Qualitative, Comparative Study in Italy and the UK
  31. Blood concentrations of neopterin and biopterin in subjects with depression: A systematic review and meta-analysis
  32. Long-acting injectable antipsychotics for the treatment of bipolar disorder: evidence from mirror-image studies
  33. Effect of long-acting injectable antipsychotics on emergency department visits and hospital admissions in people with bipolar disorder: A retrospective mirror-image analysis from the Northern Milan Area Cohort (NOMIAC) study
  34. Practical Guidance for the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia
  35. Effect of long-acting injectable antipsychotics on 1-year hospitalization in bipolar disorder: a mirror-image study
  36. A Pan-European Review of Good Practices in Early Intervention Safeguarding Practice with Children, Young People and Families: Evidence Gathering to Inform a Multi-disciplinary Training Programme (the ERICA Project) in Preventing Child Abuse and Neglect...
  37. Use of social network as a coping strategy for depression among young people during the COVID-19 lockdown: findings from the COMET collaborative study
  38. Psychotropic drug purchases during the COVID-19 pandemic in Italy and their relationship with mobility restrictions
  39. Appetite-regulating hormones in bipolar disorder: A systematic review and meta-analysis
  40. Insomnia and related factors in patients with pre-existing psychiatric disorders compared to the general population during the COVID-19 lockdown: Findings from the multicentric COMET study
  41. Innovations in community-based mental health care: an overview of meta-analyses
  42. Testing the Impact of Depressive and Anxiety Features on the Association between Attention-Deficit/Hyperactivity Disorder Symptoms and Academic Performance among University Students: A Mediation Analysis
  43. Psychopathological burden and coping strategies among frontline and second-line Italian healthcare workers facing the COVID-19 emergency: Findings from the COMET collaborative network
  44. Were anxiety, depression and psychological distress associated with local mortality rates during COVID-19 outbreak in Italy? Findings from the COMET study
  45. Clinical correlates of comorbid attention deficit hyperactivity disorder in adults suffering from bipolar disorder: A meta-analysis
  46. Off–label long acting injectable antipsychotics in real–world clinical practice: a cross-sectional analysis of prescriptive patterns from the STAR Network DEPOT study
  47. Focus on Peripheral Biomarkers of Mental Disorders
  48. Influence of positive and negative symptoms on hedonic and eudaemonic well-being in people with schizophrenia: A longitudinal analysis from the EuroSc study
  49. Digital mental health interventions for anxiety and depressive symptoms in university students during the COVID-19 pandemic: A systematic review of randomized controlled trials
  50. Acute psychiatric care: approaches to increasing the range of services and improving access and quality of care
  51. Factors Associated with Medication Adherence to Long-Acting Injectable Antipsychotics: Results from the STAR Network Depot Study
  52. Comparing 1-year effectiveness and acceptability of once-monthly paliperidone palmitate and aripiprazole monohydrate for schizophrenia spectrum disorders: Findings from the STAR Network Depot Study
  53. Demographic, clinical, and service-use characteristics related to the clinician’s recommendation to transition from child to adult mental health services
  54. Medium and long‐term efficacy of psychoeducational family intervention for bipolar I disorder: Results from a real‐world, multicentric study
  55. COVID-19-Related Social Isolation Predispose to Problematic Internet and Online Video Gaming Use in Italy
  56. Professionals’ Digital Training for Child Maltreatment Prevention in the COVID-19 Era: A Pan-European Model
  57. The impact of Covid-19 on unemployment across Italy: Consequences for those affected by psychiatric conditions
  58. The association of kynurenine pathway metabolites with symptom severity and clinical features of bipolar disorder: An overview
  59. Disentangling the Association between ADHD and Alcohol Use Disorder in Individuals Suffering from Bipolar Disorder: A Systematic Review and Meta-Analysis
  60. The Role of Attitudes Toward Medication and Treatment Adherence in the Clinical Response to LAIs: Findings From the STAR Network Depot Study
  61. Loneliness in Young Adults During the First Wave of COVID-19 Lockdown: Results From the Multicentric COMET Study
  62. Some of us are most at risk: Systematic review and meta-analysis of correlates of depressive symptoms among healthcare workers during the SARS-CoV-2 outbreak
  63. Assessing vulnerability to psychological distress during the COVID-19 pandemic through the analysis of microblogging content
  64. Thyroid hormones in persons with schizophrenia: A systematic review and meta-analysis
  65. Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials
  66. Access to Mental Health Care during the First Wave of the COVID-19 Pandemic in Italy: Results from the COMET Multicentric Study
  67. What Is the Role of Resilience and Coping Strategies on the Mental Health of the General Population during the COVID-19 Pandemic? Results from the Italian Multicentric COMET Study
  68. Family members’ perspectives of child protection services, a metasynthesis of the literature
  69. A longitudinal analysis of a work inclusion model for psychiatric patients in the Mental Health Departments of the city of Milan
  70. A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic
  71. Longitudinal symptomatic interactions in long-standing schizophrenia: a novel five-point analysis based on directed acyclic graphs
  72. The kynurenine pathway in schizophrenia and other mental disorders: Insight from meta-analyses on the peripheral blood levels of tryptophan and related metabolites
  73. A Systematic Review of Non-pharmacological Strategies to Reduce the Risk of Violence in Patients With Schizophrenia Spectrum Disorders in Forensic Settings
  74. Immune-inflammatory markers and psychosis risk: A systematic review and meta-analysis
  75. Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey
  76. Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic Study
  77. Efficacy of Cannabidiol for Δ-9-Tetrahydrocannabinol-Induced Psychotic Symptoms, Schizophrenia, and Cannabis Use Disorders: A Narrative Review
  78. Pharmacological interventions to reduce violence in patients with schizophrenia in forensic psychiatry
  79. Surveilling COVID-19 Emotional Contagion on Twitter by Sentiment Analysis
  80. Did we learn something positive out of the COVID-19 pandemic? Post-traumatic growth and mental health in the general population
  81. Textbook of Addiction Treatment
  82. Pre-Discharge Predictors of 1-Year Rehospitalization in Adolescents and Young Adults with Severe Mental Disorders: A Retrospective Cohort Study
  83. Special Populations: An Introduction
  84. Clinical correlates of DSM-5 mixed features in bipolar disorder: A meta-analysis
  85. The kynurenine pathway in bipolar disorder: a meta-analysis on the peripheral blood levels of tryptophan and related metabolites
  86. Substance use disorders and violent behaviour in patients with severe mental disorders: A prospective, multicentre study
  87. How to improve adherence to antidepressant treatments in patients with major depression: a psychoeducational consensus checklist
  88. Effects of the lockdown on the mental health of the general population during the COVID-19 pandemic in Italy: results from the COMET Collaborative Network
  89. Tolerability and efficacy of vortioxetine versus SSRIs in elderly with major depression. Study protocol of the VESPA study: a pragmatic, multicentre, open-label, parallel-group, superiority, randomized trial
  90. Glial and neuronal markers in bipolar disorder: A meta-analysis testing S100B and NSE peripheral blood levels
  91. The Impact of Quarantine and Physical Distancing Following COVID-19 on Mental Health: Study Protocol of a Multicentric Italian Population Trial
  92. COVID-19 and Substance Use Disorders as Brain Diseases: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group Position Paper
  93. Cannabidiol for Mood Disorders: A Call for More Research
  94. Clinical correlates of paliperidone palmitate and aripiprazole monohydrate prescription for subjects with schizophrenia-spectrum disorders
  95. Chemokine alterations in bipolar disorder: A systematic review and meta-analysis
  96. Purinergic Signaling and Related Biomarkers in Depression
  97. Detecting Binge Drinking and Alcohol-Related Risky Behaviours from Twitter’s Users: An Exploratory Content- and Topology-Based Analysis
  98. Prescribing Patterns of Psychotropic Drugs and Risk of Violent Behavior: A Prospective, Multicenter Study in Italy
  99. Reasons for initiating long-acting antipsychotics in psychiatric practice: findings from the STAR Network Depot Study
  100. Studying Patients with Severe Mental Disorders Who Act Violently: Italian and European Projects
  101. European violence risk and mental disorders (EU-VIORMED): a multi-centre prospective cohort study protocol
  102. Publisher Correction: Self-harm behaviour and externally-directed aggression in psychiatric outpatients: a multicentre, prospective study (viormed-2 study)
  103. Self-harm behaviour and externally-directed aggression in psychiatric outpatients: a multicentre, prospective study (viormed-2 study)
  104. Personality, Schizophrenia, and Violence: A Longitudinal Study: The Second Wave of the VIORMED Project
  105. Cannabis use disorder and suicide attempts in bipolar disorder: A meta-analysis
  106. More anxious than depressed: prevalence and correlates in a 15-nation study of anxiety disorders in people with type 2 diabetes mellitus
  107. Facial emotion recognition in people with schizophrenia and a history of violence: a mediation analysis
  108. Violence risk and mental disorders (VIORMED-2): A prospective multicenter study in Italy
  109. Ketamine for suicidal ideation treatment: Available evidence remains convincing
  110. Trends of major depressive episode among people with cannabis use: Findings from the National Survey on Drug Use and Health 2006–2015
  111. The mediating role of depression in pathways linking positive and negative symptoms in schizophrenia. A longitudinal analysis using latent variable structural equation modelling
  112. Differences in serum uric acid between ‘unipolar’ and ‘bipolar’ depression: Preliminary data
  113. Positive and negative symptoms in schizophrenia: A longitudinal analysis using latent variable structural equation modelling
  114. Adjunctive second-generation antipsychotics for specific symptom domains of schizophrenia resistant to clozapine: A meta-analysis
  115. Recent suicide attempts and serum lipid profile in subjects with mental disorders: A cross-sectional study
  116. Untreated depression and non-medical use of prescription pain relievers: findings from the National Survey on Drug Use and Health 2008-2014
  117. Testing the association of serum uric acid levels with behavioral and clinical characteristics in subjects with major affective disorders: A cross-sectional study
  118. Early Post-stroke Depression and Mortality: Meta-Analysis and Meta-Regression
  119. Facial emotion recognition performance influences executive control impairment in Anorexia Nervosa: an exploratory study
  120. Poverty matters: Cannabis use among people with serious mental illness: Findings from the United States survey on drug use and health, 2015
  121. Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy
  122. Knowledge and utilization of technology-based interventions for substance use disorders: an exploratory study among health professionals in the European Union
  123. Predicting Young Adults Binge Drinking in Nightlife Scenes
  124. Purinergic system and suicidal behavior: exploring the link between adenosine A2A receptors and depressive/impulsive features
  125. The effects of psychoeducational family intervention on coping strategies of relatives of patients with bipolar I disorder: results from a controlled, real-world, multicentric study
  126. Insomnia as an additional clinical correlate of suicidal ideation after stroke
  127. Testing the role of the antioxidant uric acid as a biomarker of suicidal ideation in subjects with major affective disorders: An exploratory study
  128. Effect of clinical response to active drugs and placebo on antipsychotics and mood stabilizers relative efficacy for bipolar depression and mania: A meta-regression analysis
  129. Antidepressant Response and Dissociative Effects After Ketamine Treatment
  130. Engagement in the Overdose RIsk InfOrmatioN (ORION) e-Health Tool for Opioid Overdose Prevention and Self-Efficacy: A Preliminary Study
  131. The antioxidant uric acid and depression: clinical evidence and biological hypotheses
  132. Lipid profile and suicide attempt in bipolar disorder: A meta-analysis of published and unpublished data
  133. Facial emotion recognition in schizophrenia: An exploratory study on the role of comorbid alcohol and substance use disorders and COMT Val158Met
  134. Social network confidants, duration of untreated psychosis and cannabis use in people with first episode psychosis: An exploratory study
  135. Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature
  136. Gambling, geographical variations and deprivation: findings from the adult psychiatric morbidity survey
  137. Risk and maintenance factors for young women’s DSM-5 eating disorders
  138. Neuroactive steroid levels and psychiatric and andrological features in post-finasteride patients
  139. Antioxidant uric acid in treated and untreated subjects with major depressive disorder: a meta-analysis and meta-regression
  140. Ketamine as a rapid-acting agent for suicidal ideation: A meta-analysis
  141. Acute variations of cytokine levels after antipsychotic treatment in drug-naïve subjects with a first-episode psychosis: A meta-analysis
  142. Benefits and harms of low and high second-generation antipsychotics doses for bipolar depression: A meta-analysis
  143. Purinergic dysfunction in bipolar disorder: Any role for the antioxidant uric acid as a trait and state biomarker?
  144. Association between total serum cholesterol and suicide attempts in subjects with major depressive disorder: Exploring the role of clinical and biochemical confounding factors
  145. Rates and correlates of suicidal ideation among stroke survivors: a meta-analysis
  146. Executive control in schizophrenia: a preliminary study on the moderating role of COMT Val158Met for comorbid alcohol and substance use disorders
  147. Web- and text-based interventions for smoking cessation: Meta-analysis and meta-regression
  148. Purinergic system dysfunctions in subjects with bipolar disorder: A comparative cross-sectional study
  149. Single and Multiple Clinical Syndromes in Incarcerated Offenders: Associations With Dissociative Experiences and Emotionality
  150. Allopurinol as add-on treatment for mania symptoms in bipolar disorder: Systematic review and meta-analysis of randomised controlled trials
  151. Update on bipolar disorder biomarker candidates: what about uric acid/adenosine hypothesis?
  152. Agreement between DSM-IV and DSM-5 criteria for alcohol use disorder among outpatients suffering from depressive and anxiety disorders
  153. Stigmatizing Attitudes and Beliefs About Anorexia and Bulimia Nervosa Among Italian Undergraduates
  154. Area-Level Deprivation and Adverse Consequences in People With Substance Use Disorders: Findings From the Psychiatric and Addictive Dual Disorder in Italy (PADDI) Study
  155. Quality assurance in drug demand reduction in European countries: an overview
  156. Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder?
  157. Uric acid levels in subjects with bipolar disorder: A comparative meta-analysis
  158. Testing the DSM-5 severity indicator for bulimia nervosa in a treatment-seeking sample
  159. Predicting onset and maintenance of men's eating disorders
  160. Decision support in addiction: The development of an e-health tool to assess and prevent risk of fatal overdose. The ORION Project
  161. Clinical utility of a single-item test for DSM-5 alcohol use disorder among outpatients with anxiety and depressive disorders
  162. Objectified Body Consciousness (OBC) in Eating Psychopathology
  163. Validity and clinical utility of the DSM-5 severity specifier for bulimia nervosa: results from a multisite sample of patients who received evidence-based treatment
  164. Dysfunctional bodily experiences in anorexia nervosa: where are we?
  165. First-generation antipsychotics and QTc: any role for mediating variables?
  166. Psychosocial functioning, quality of life and clinical correlates of comorbid alcohol and drug dependence syndromes in people with schizophrenia across Europe
  167. Exploring the association between bipolar disorder and uric acid: A mediation analysis
  168. Impact of a Mobile E-Health Intervention on Binge Drinking in Young People: The Digital–Alcohol Risk Alertness Notifying Network for Adolescents and Young Adults Project
  169. Body-image distortion in anorexia nervosa
  170. Predictors of initiation and persistence of recurrent binge eating and inappropriate weight compensatory behaviors in college men
  171. Social psychiatry
  172. Prospective Psychosocial Predictors of Onset and Cessation of Eating Pathology amongst College Women
  173. Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval
  174. Building ties in the community for patients with mental illness
  175. Association between depression and neuropathy in people with type 2 diabetes: a meta-analysis
  176. Disentangling the Association Between Child Abuse and Eating Disorders
  177. Metabolic Syndrome Among People with PTSD: Epidemiological Overview
  178. Feasibility of a psychoeducational family intervention for people with bipolar I disorder and their relatives: Results from an Italian real-world multicentre study
  179. Out of body, out of space: Impaired reference frame processing in eating disorders
  180. Facial emotion recognition in alcohol and substance use disorders: A meta-analysis
  181. Narcissistic Vulnerability and Grandiosity as Mediators Between Insecure Attachment and Future Eating Disordered Behaviors: A Prospective Analysis of Over 2,000 Freshmen
  182. The association between PTSD and metabolic syndrome: A role for comorbid depression?
  183. Posttraumatic Stress Disorder and Risk of Obesity
  184. Prevalence and correlates of QTc prolongation in Italian psychiatric care: cross-sectional multicentre study
  185. Second-generation antipsychotics and adiponectin levels in schizophrenia: A comparative meta-analysis
  186. E-health app to reduce binge drinking among adolescents and young adults: the D-ARIANNA Project
  187. Benzodiazepine and training
  188. Schizoaffective disorder and metabolic syndrome: A meta-analytic comparison with schizophrenia and other non-affective psychoses
  189. Plasma adiponectin levels in schizophrenia and role of second-generation antipsychotics: A meta-analysis
  190. The Social Appearance Anxiety Scale in Italian Adolescent Populations: Construct Validation and Group Discrimination in Community and Clinical Eating Disorders Samples
  191. A review of regional drug strategies across the world: How is prevention perceived and addressed?
  192. Mechanisms of influence of body checking on binge eating
  193. Correlates of dependence and treatment for substance use among people with comorbid severe mental and substance use disorders
  194. Facial Emotion Recognition and Disorganization in Subjects with Schizophrenia and Alcohol, Substance Use Disorder
  195. From DSM-IV to DSM-5 alcohol use disorder: An overview of epidemiological data
  196. Efficacy of psychoeducational family intervention for bipolar I disorder: A controlled, multicentric, real-world study
  197. Textbook of Addiction Treatment: International Perspectives
  198. Metabolic Syndrome Among People with PTSD: Epidemiological Overview
  199. Cannabis use disorder as a correlate of suicide attempts among people with bipolar disorder
  200. Special Populations: An Introduction
  201. Psychiatric Comorbidities and Complications of Alcohol and Other Drugs: An Introduction
  202. Comorbid Anxiety and Alcohol or Substance Use Disorders: An Overview
  203. Main Elements of a Systems Approach to Addiction Treatment: An Introduction
  204. Psychotic Disorders and Substance Use Disorders
  205. Testing the cognitive-behavioural maintenance models across DSM-5 bulimic-type eating disorder diagnostic groups: a multi-centre study
  206. The developmental effects of media-ideal internalization and self-objectification processes on adolescents’ negative body-feelings, dietary restraint, and binge eating
  207. Cardiovascular risk factors among people with severe mental illness in Italy: A cross-sectional comparative study
  208. Testing the original and the extended dual-pathway model of lack of control over eating in adolescent girls. A two-year longitudinal study
  209. Attempted suicide in people with co-occurring bipolar and substance use disorders: Systematic review and meta-analysis
  210. Comorbid Addiction and Major Mental Illness in Europe: A Narrative Review
  211. Efforts to make clearer the relationship between body dissatisfaction and binge eating
  212. Risk Estimation Modeling and Feasibility Testing for a Mobile eHealth Intervention for Binge Drinking Among Young People: The D-ARIANNA (Digital-Alcohol RIsk Alertness Notifying Network for Adolescents and young adults) Project
  213. The prevalence of metabolic syndrome in people with severe mental illness: a mediation analysis
  214. Attachment insecurities, maladaptive perfectionism, and eating disorder symptoms: A latent mediated and moderated structural equation modeling analysis across diagnostic groups
  215. Prevalence and Correlates of Binge Drinking among Young Adults Using Alcohol: A Cross-Sectional Survey
  216. Association between depression and non-fatal overdoses among drug users: A systematic review and meta-analysis
  217. Metabolic Syndrome in People Suffering from Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis
  218. Bipolar Disorder, Schizophrenia, and Metabolic Syndrome
  219. Depression after Stroke and Risk of Mortality: A Systematic Review and Meta-Analysis
  220. 1882 – The association between post-stroke depression and mortality: a metaanalysis
  221. 1842 – Severe mental illness and metabolic syndrome: a meta-analysis
  222. Perché è importante una federazione europea delle società delle tossicodipendenze?
  223. The association between expressed emotion, illness severity and subjective burden of care in relatives of patients with schizophrenia. Findings from an Italian population
  224. Tossicodipendenze, comorbilità e “doppia diagnosi”
  225. The lifetime and past-year prevalence of dual diagnosis in people with schizophrenia across Europe: findings from the European Schizophrenia Cohort (EuroSC)
  226. Training in Community Psychiatry
  227. Do they actually work across borders? Evaluation of two measures of psychological distress as screening instruments in a non Anglo-Saxon country
  228. MULTIPLE GROUP FAMILY TREATMENT FOR SCHIZOPHRENIA IN ITALY
  229. S14-01 Geographical variations for addiction risk among dually diagnosed people cared in parallel systems
  230. Alcohol Misuse in People with Schizophrenia: Findings from the Paddi (psychiatric and Addictive Dual Diagnosis in Italy) Study
  231. And how shall we deal with adaptation and implementation of NICE schizophrenia guidelines in Italy?
  232. The SIEP-DIRECT's Project on the discrepancy between routine practice and evidence. An outline of main findings and practical implications for the future of community based mental health services
  233. The treatment of acute psychotic episode: discrepancy between routine practice and evidence. The project SIEP-DIRECT's
  234. Promoting recovery of schizophrenic patients: discrepancy between routine practice and evidence. The SIEP-DIRECT's Project
  235. Care across all phases of schizophrenia and initiation of treatment: discrepancy between routine practice and evidence. The SIEP-DIRECT's Project
  236. Management of violent behaviour and rapid tranquillisation during acute psychotic episode: discrepancy between routine practice and evidence. The SIEP-DIRECT's Project
  237. The acceptability of the NICE recommendations for schizophrenia in the Italian Departments of Mental Health. The SIEP-DIRECT's Project on the discrepancy between routine practice and evidence
  238. Variations in rates of comorbid substance use in psychosis between mental health settings and geographical areas in the UK
  239. Does HIV serostatus affect outcomes of dually diagnosed opiate dependents in residential treatment?
  240. 0188 SOCIAL NETWORKS IN FIRST EPISODE PSYCHOSIS
  241. 0189 SUBSTANCE USE IN FIRST EPISODE PSYCHOSIS
  242. Family interventions for schizophrenia in Italy: randomized controlled trial
  243. Dual Diagnosis—Policy and Practice in Italy
  244. Severity Profiles of Substance-Abusing Patients in Italian Community Addiction Facilities: Influence of Psychiatric Concurrent Disorders
  245. Cesare Lombroso, M.D., 1835–1909
  246. Cesare Lombroso, M.D., 1835-1909
  247. Prevalence of mental disorder and related treatments in a local jail: a 20-month consecutive case study
  248. The Italian Association on Addiction Psychiatry (SIPDip), formerly The Italian Association on Abuse and Addictive Behaviours
  249. Schizofrenia e intervento psicosociale sulle famiglie. Indagine sulle caratteristiche dell'utenza e follow-up ad un anno